Evaluation of effectiveness of bacteriophage purification methods

Area of Science:

• Microbiology
• Biotechnology
• Therapeutic Development

Background:

• Bacteriophage therapy is gaining traction, but lacks standardized purification methods for clinical use.
• Current emergency access to bacteriophage therapy bypasses standard Good Manufacturing Practice (GMP) certification.
• Ensuring bacteriophage safety requires effective endotoxin removal, a critical but unstandardized step.

Purpose of the Study:

• To evaluate the endotoxin removal efficacy of three common bacteriophage purification techniques.
• To assess the impact of purification methods on bacteriophage yield and immune response.
• To determine if bacteriophage morphology influences endotoxin removal efficiency.

Main Methods:

• Utilized an Interleukin Receptor Associated Kinase (IRAK) 3 knockout monocyte-based assay to measure endotoxin levels.
• Tested purification methods on three bacteriophage morphotypes: siphovirus, podovirus, and myovirus.
• Compared Triton X-100 exposure, CsCl density gradient ultracentrifugation, and Pierce™ High-Capacity Endotoxin Removal Resin spin columns.

Main Results:

• Triton X-100 treatment and CsCl density gradient ultracentrifugation significantly reduced endotoxin levels and immune responses.
• Pierce™ High-Capacity Endotoxin Removal Resin spin columns were less effective in endotoxin removal.
• Triton X-100 purification resulted in the lowest loss of bacteriophage titres.
• Bacteriophage morphology did not appear to affect endotoxin removal efficacy.

Conclusions:

• Triton X-100 and CsCl density gradient ultracentrifugation are superior methods for purifying bacteriophages for therapeutic use, balancing safety and yield.
• Standardized purification protocols are crucial for the safe and effective clinical application of bacteriophage therapy.
• Further research into GMP-compliant purification is essential for regulatory approval and widespread adoption of bacteriophage therapy.